Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$534M |
| 2 |
Amazon
AMZN
|
+$399M |
| 3 |
Abbott
ABT
|
+$381M |
| 4 |
Adobe
ADBE
|
+$353M |
| 5 |
Oracle
ORCL
|
+$261M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sherwin-Williams
SHW
|
+$407M |
| 2 |
Bank of America
BAC
|
+$368M |
| 3 |
TE Connectivity
TEL
|
+$366M |
| 4 |
Goldman Sachs
GS
|
+$302M |
| 5 |
Atlassian
TEAM
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.57% |
| 2 | Healthcare | 19.51% |
| 3 | Consumer Discretionary | 9.79% |
| 4 | Industrials | 9.79% |
| 5 | Financials | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IMGN
126
DELISTED
Immunogen Inc
IMGN
| $327M | 0.2% |
11,043,986
-6,640,830
| -38% | -$132M |
|
127
Sysco
SYY
$40.8B
| $323M | 0.19% |
4,416,575
-76,985
| -2% | -$5.31M |
|
128
Cboe Global Markets
CBOE
$30.9B
| $323M | 0.19% |
1,807,337
-144,835
| -7% | -$24.8M |
|
129
TSMC
TSM
$2.03T
| $321M | 0.19% |
3,086,757
+22,680
| +0.7% | +$2.16M |
|
130
Oneok
OKE
$55.7B
| $315M | 0.19% |
4,492,001
-8,173
| -0.2% | -$548K |
|
131
Fortive
FTV
$19.5B
| $313M | 0.19% |
5,632,219
+1,700,506
| +43% | +$89.7M |
|
132
O'Reilly Automotive
ORLY
$76.2B
| $312M | 0.19% |
4,929,855
-705,780
| -13% | -$44.6M |
|
133
Canadian Natural Resources
CNQ
$92.7B
| $310M | 0.19% |
9,459,066
+665,676
| +8% | +$21.5M |
|
134
Humana
HUM
$46.2B
| $303M | 0.18% |
661,567
-76,282
| -10% | -$37.6M |
|
135
iShares Core US Aggregate Bond ETF
AGG
$138B
| $293M | 0.17% |
2,951,669
-21,471
| -0.7% | -$2.04M |
|
136
Trane Technologies
TT
$103B
| $289M | 0.17% |
1,186,155
-60,954
| -5% | -$13.3M |
|
137
Amgen
AMGN
$211B
| $289M | 0.17% |
1,004,126
+73,147
| +8% | +$19.9M |
|
138
Medtronic
MDT
$111B
| $289M | 0.17% |
3,501,656
-231,038
| -6% | -$17.6M |
|
139
Prologis
PLD
$138B
| $284M | 0.17% |
2,127,960
-205,046
| -9% | -$23.3M |
|
140
Eaton
ETN
$150B
| $275M | 0.16% |
1,141,454
+299,417
| +36% | +$66.1M |
|
141
Global Payments
GPN
$23.6B
| $274M | 0.16% |
2,160,650
-3,608
| -0.2% | -$418K |
|
142
Dentsply Sirona
XRAY
$2.68B
| $270M | 0.16% |
7,583,187
+157,848
| +2% | +$5.01M |
|
143
BioMarin Pharmaceuticals
BMRN
$12B
| $269M | 0.16% |
2,790,343
-634,196
| -19% | -$56.1M |
|
144
Cisco
CSCO
$461B
| $267M | 0.16% |
5,292,258
-3,907,765
| -42% | -$200M |
|
145
Equinix
EQIX
$104B
| $267M | 0.16% |
330,954
+57,899
| +21% | +$44.5M |
|
146
CRH
CRH
$69.1B
| $265M | 0.16% |
3,841,036
-155,196
| -4% | -$9.37M |
|
147
Rockwell Automation
ROK
$52.5B
| $264M | 0.16% |
849,845
-14,779
| -2% | -$4.14M |
|
148
Clean Harbors
CLH
$16B
| $263M | 0.16% |
1,507,613
+80,559
| +6% | +$13.2M |
|
149
ICU Medical
ICUI
$4.17B
| $261M | 0.16% |
2,617,933
+93,157
| +4% | +$9.11M |
|
150
Hershey
HSY
$36.8B
| $261M | 0.16% |
1,397,236
-31,101
| -2% | -$5.89M |
|
Similar funds
Janus Henderson Group's Q4 2023 Portfolio in Review
As of Q4 2023, Janus Henderson Group held 2,657 positions worth $168B, up 9.8% from $153B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Janus Henderson Group's Q4 2023 filing shows 98 new, 642 increased, 1,760 reduced and 111 closed positions. Its largest new stake was Veralto: 2,881,576 shares worth $237M. The largest sale was Sherwin-Williams, an estimated $407M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q4 2023 buy was Veralto: 2,881,576 shares worth $237M.
- Janus Henderson Group added most to Eli Lilly in Q4 2023, an estimated $534M increase.
- Janus Henderson Group's biggest Q4 2023 reduction was Sherwin-Williams, cutting an estimated $407M.
- Janus Henderson Group fully exited National Instruments Corp in Q4 2023, selling an estimated $243M.
- Janus Henderson Group's ten largest holdings make up 27% of its $168B portfolio in Q4 2023.
- Janus Henderson Group opened 98 new positions and closed 111 in Q4 2023.
- Janus Henderson Group's portfolio value rose 9.8% quarter-over-quarter to $168B.
Based on Janus Henderson Group's 13F filing for Q4 2023, filed 14 Feb 2024.